501 related articles for article (PubMed ID: 22659596)
1. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Activity Measurements of Brown Adipose Tissue at 7 T Magnetic Resonance Imaging After Application of Triglyceride-Rich Lipoprotein 59Fe-Superparamagnetic Iron Oxide Nanoparticle: Intravenous Versus Intraperitoneal Approach.
Jung CS; Heine M; Freund B; Reimer R; Koziolek EJ; Kaul MG; Kording F; Schumacher U; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
Invest Radiol; 2016 Mar; 51(3):194-202. PubMed ID: 26674208
[TBL] [Abstract][Full Text] [Related]
3. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
4. Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes.
Puppi J; Mitry RR; Modo M; Dhawan A; Raja K; Hughes RD
Cell Transplant; 2011; 20(6):963-75. PubMed ID: 21092412
[TBL] [Abstract][Full Text] [Related]
5. Thiol-PEG-carboxyl-stabilized Fe₂O ₃/Au nanoparticles targeted to CD105: synthesis, characterization and application in MR imaging of tumor angiogenesis.
Zhang S; Gong M; Zhang D; Yang H; Gao F; Zou L
Eur J Radiol; 2014 Jul; 83(7):1190-1198. PubMed ID: 24832501
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.
Sterenczak KA; Meier M; Glage S; Meyer M; Willenbrock S; Wefstaedt P; Dorsch M; Bullerdiek J; Murua Escobar H; Hedrich H; Nolte I
BMC Cancer; 2012 Jul; 12():284. PubMed ID: 22784304
[TBL] [Abstract][Full Text] [Related]
7. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.
Roohi F; Lohrke J; Ide A; Schütz G; Dassler K
Int J Nanomedicine; 2012; 7():4447-58. PubMed ID: 22927759
[TBL] [Abstract][Full Text] [Related]
8. In vivo visualization and ex vivo quantification of murine breast cancer cells in the mouse brain using MRI cell tracking and electron paramagnetic resonance.
Danhier P; Magat J; Levêque P; De Preter G; Porporato PE; Bouzin C; Jordan BF; Demeur G; Haufroid V; Feron O; Sonveaux P; Gallez B
NMR Biomed; 2015 Mar; 28(3):367-75. PubMed ID: 25611487
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
10. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
11. Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection.
Xu F; Lei D; Du X; Zhang C; Xie X; Yin D
Contrast Media Mol Imaging; 2011; 6(1):46-54. PubMed ID: 20865697
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of positive contrast imaging techniques for molecular MRI of tumor angiogenesis.
Wolters M; Oostendorp M; Coolen BF; Post MJ; Janssen JM; Strijkers GJ; Kooi ME; Nicolay K; Backes WH
Contrast Media Mol Imaging; 2012; 7(2):130-9. PubMed ID: 22434625
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
14. Seven-tesla magnetic resonance imaging accurately quantifies intratumoral uptake of therapeutic nanoparticles in the McA rat model of hepatocellular carcinoma: preclinical study in a rodent model.
Tyler PD; McDevitt JL; Sheu AY; Nicolai J; Procissi D; Ragin AB; Lewandowski RJ; Salem R; Larson AC; Omary RA
Invest Radiol; 2014 Feb; 49(2):87-92. PubMed ID: 24089022
[TBL] [Abstract][Full Text] [Related]
15. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
Sano K
Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
[TBL] [Abstract][Full Text] [Related]
16. Mapping of proton relaxation near superparamagnetic iron oxide particle-loaded polymer threads for magnetic susceptibility difference quantification.
Donker HC; Krämer NA; Otto J; Klinge U; Slabu I; Baumann M; Kuhl CK
Invest Radiol; 2012 Jun; 47(6):359-67. PubMed ID: 22543968
[TBL] [Abstract][Full Text] [Related]
17. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of pathogenic protozoan parasite Entamoeba histolytica labeled with superparamagnetic iron oxide nanoparticles.
Ernst TM; Fehling H; Bernin H; Zaruba MD; Bruchhaus I; Adam G; Ittrich H; Lotter H
Invest Radiol; 2015 Oct; 50(10):709-18. PubMed ID: 26135016
[TBL] [Abstract][Full Text] [Related]
19. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
20. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
Smirnov P
Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]